EVAX
Evaxion A/S
$3.25
-0.06 (-1.81%)
At close · Jul 8
Market Cap
$27.11M
Shares
8,340,215
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.25
Open$3.37
Day$3.20–3.42
52W$2.30–12.15
Avg vol 30d30K
Short int30K · 0.4% float · 1.0d
Short vol17%
Last earningsMar 31, 2026
DataFeb 2021–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−28%
below
Price vs 50-day avg
−15%
below
RSI (14)
43
neutral
MACD trend
Positive
52-week position
10%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−13%
trailing
6-month return
−36%
trailing
YTD return
−32%
this year
Relative strength
−44%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Distributing
1 of 16 funds reported for Jun 30 · net -586 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.36% of float · ▲ +21.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
16 holders — near 1-yr high, broad support
Squeeze score
23
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
114%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
8.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
Operational cash burn
· 2026
Initiated
$14M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−28%
Bearish
Price vs 50-day avg
−15%
Bearish
RSI (14)
43
Neutral
MACD trend
Positive
Bullish
52-week position
10%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Distributing
1 of 16 funds reported for Jun 30 · net -586 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.36% of float · ▲ +21.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
16 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $3 · 10%
52-wk high $12
vs 200-day avg -28%
vs 50-day avg -15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| de novo T-cell response rate | 86% | Q1 2026 call | — |
| immunogenicity conversion rate | 86% | Q1 2026 call | — |
| vaccine targets triggering specific immune response | 86% | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EVAX
this stock
Evaxion A/S
|
$27.11M | -31.9% | — | — | 0.4% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EVAX | +4.8% | -12.9% | -36.3% | +4.8% | -31.9% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +5.0% | -13.7% | -43.7% | +5.0% | -41.2% |